Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Hyungkun | - |
dc.contributor.author | Oh, Dong Jae | - |
dc.contributor.author | Suh, Ho-Suk | - |
dc.contributor.author | Lee, Kyoung-Uk | - |
dc.contributor.author | Lim, Se-Won | - |
dc.contributor.author | Lee, Jun-Yeob | - |
dc.contributor.author | Yang, Jong-Chul | - |
dc.contributor.author | Lee, Jae-Hon | - |
dc.contributor.author | Ha, Juwon | - |
dc.contributor.author | Lee, Bun-Hee | - |
dc.contributor.author | Kang, Seung-Gul | - |
dc.contributor.author | Yoon, Ho-Kyoung | - |
dc.contributor.author | Moon, Jihyun | - |
dc.contributor.author | Bae, Seung-Min | - |
dc.contributor.author | Kwon, Youngdo | - |
dc.contributor.author | Kim, Hyun-Chung | - |
dc.contributor.author | Oh, Kang Seob | - |
dc.date.accessioned | 2021-09-02T15:57:45Z | - |
dc.date.available | 2021-09-02T15:57:45Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-02 | - |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77890 | - |
dc.description.abstract | Objective The aim of the present study was to provide clinical consensus and evidence regarding initial treatment strategies for the pharmacological treatment of social anxiety disorder (SAD) in Korea. Methods We prepared a questionnaire to derive a consensus from clinicians regarding their preference for the pharmacological treatment of SAD in Korea. Data regarding medication regimens and psychotropic drugs used during initial treatment, the doses used, and the pharmacological treatment duration were obtained. Responses were obtained from 66 SAD experts, and their opinions were classified into three categories (first-line, second-line, third-line) using a chi-square analysis. Results Clinicians agreed upon first-line regimens for SAD involving monotherapy with selective serotonin reuptake inhibitors (SS-RIs) or the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine, or combined therapy using antidepressants with beta-blockers or benzodiazepines on a standing or as-needed basis. First-line psychotropic drug choices for initial treatment included the following: escitalopram, paroxetine, sertraline, venlafaxine, and propranolol. The medication dosage used by domestic clinicians was found to be comparable with foreign guidelines. Domestic clinicians tended to make treatment decisions in a shorter amount of time and preferred a similar duration of maintenance treatment for SAD when compared with foreign clinicians. Conclusion This study may provide significant information for developing SAD pharmacotherapy guidelines in Korea, especially in the early stage of treatment. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN NEUROPSYCHIATRIC ASSOC | - |
dc.subject | RECOMMENDATIONS | - |
dc.title | Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Ho-Kyoung | - |
dc.identifier.doi | 10.30773/pi.2017.05.01 | - |
dc.identifier.scopusid | 2-s2.0-85042540474 | - |
dc.identifier.wosid | 000426120900009 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY INVESTIGATION, v.15, no.2, pp.147 - 155 | - |
dc.relation.isPartOf | PSYCHIATRY INVESTIGATION | - |
dc.citation.title | PSYCHIATRY INVESTIGATION | - |
dc.citation.volume | 15 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 147 | - |
dc.citation.endPage | 155 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002315762 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | RECOMMENDATIONS | - |
dc.subject.keywordAuthor | Social anxiety disorder | - |
dc.subject.keywordAuthor | Guideline | - |
dc.subject.keywordAuthor | Initial treatment | - |
dc.subject.keywordAuthor | Pharmacotherapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.